Synonym: (+)-(S)-4,4′-Propylenedi-2,6-piperazinedione; (S)-(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane; Cardioxane; ICRF-187; NSC169780; Zinecard
CAS Number: 24584-09-6
Empirical Formula (Hill Notation): C11H16N4O4
Molecular Weight: 268.27
MDL Number: MFCD00866449
Linear Formula: C11H16N4O4
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts D1446-25MG
| assay |
≥95% (HPLC) |
| color |
white to off-white |
| form |
powder |
| InChI |
1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1 |
| InChI key |
BMKDZUISNHGIBY-ZETCQYMHSA-N |
| originator |
Johnson & Johnson |
| Quality Level |
100  |
| SMILES string |
C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2 |
| solubility |
DMSO: >20 mg/mL |
| storage temp. |
room temp |
| Application: |
Dexrazoxane has been used in chromatin remodelling experiments. |
| Biochem/physiol Actions: |
Dexrazoxane is a cardioprotective compound against anthracyclines. It functions by inhibiting topoisomerase II without inducing DNA strand breaks. Dexrazoxane is a + enantiomer of razoxane. |
| Biochem/physiol Actions: |
Dexrazoxane is a cardioprotective compound used to counteract the effects of anthracyclines. Dexrazoxane is believed to function as a free radical scanenger. |
| Features and Benefits: |
This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: |
This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: |
Dexrazoxane is a member of bis(2,6-dioxopiperazines), that functions as a topoisomerase 2 catalytic inhibitor. Dexrazoxane is a free radical scavenger. It might protect the heart from doxorubicin-associated damage. Dexrazoxane acts as a cardiopulmonary protectant, while treating Hodgkin′s disease (HD). It functions as a chelating agent, which limits the formation of anthracycline-iron complexes. It is used to synthesize antimalarial drugs. |
| Packaging: |
5, 25 mg in glass bottle |
| Purity |
≥95% (HPLC) |
| Storage Temp. |
room temp |
| UNSPSC |
12352200 |